WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity
WuXi AppTec (OTC:WUXAY), a global provider of R&D and manufacturing services for the pharmaceutical industry, announced that its Nantong site (Phase I) has won the Popular Choice Winner award in the "Factory & Warehouse" category at the 2025 Architizer A+Awards.
The Nantong site, located in Jiangsu province, China, features eight main buildings arranged in two clusters and serves as a key component of WuXi AppTec's CRDMO platform. The facility's design emphasizes 'technological-humanistic symbiosis', incorporating operational efficiency with human-centered design elements. The site provides comprehensive chemistry, biology, and testing solutions to global customers.
WuXi AppTec (OTC:WUXAY), fornitore globale di servizi di R&S e produzione per l'industria farmaceutica, ha annunciato che il suo sito di Nantong (Fase I) ha vinto il premio Popular Choice Winner nella categoria "Factory & Warehouse" agli Architizer A+Awards 2025.
Il sito di Nantong, situato nella provincia di Jiangsu, in Cina, comprende otto edifici principali disposti in due cluster ed 猫 una componente fondamentale della piattaforma CRDMO di WuXi AppTec. Il design della struttura enfatizza la "simbiosi tecnologico-umanistica", unendo efficienza operativa a elementi di design incentrati sull'uomo. Il sito offre soluzioni complete di chimica, biologia e testing a clienti globali.
WuXi AppTec (OTC:WUXAY), proveedor global de servicios de I+D y fabricaci贸n para la industria farmac茅utica, anunci贸 que su sitio de Nantong (Fase I) gan贸 el premio Popular Choice Winner en la categor铆a "Factory & Warehouse" en los Architizer A+Awards 2025.
El sitio de Nantong, ubicado en la provincia de Jiangsu, China, cuenta con ocho edificios principales organizados en dos grupos y es una parte clave de la plataforma CRDMO de WuXi AppTec. El dise帽o de la instalaci贸n enfatiza la "simbiosis tecnol贸gico-humanista", combinando eficiencia operativa con elementos de dise帽o centrados en el ser humano. El sitio ofrece soluciones integrales de qu铆mica, biolog铆a y pruebas para clientes globales.
WuXi AppTec (OTC:WUXAY)電� 鞝滌暯 靷办梾鞚� 鞙勴暅 鞐瓣惮臧滊皽 氚� 鞝滌“ 靹滊箘鞀るゼ 鞝滉车頃橂姅 旮�搿滊矊 旮办梾鞙茧, 雮滍墎 靷澊韸�(1雼硠)臧赌 2025 Architizer A+Awards鞚� "Factory & Warehouse" 攵�氍胳棎靹� 鞚戈赴靸�(Popular Choice Winner)鞚� 靾橃儊頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟.
欷戧淡 鞛レ懁靹膘棎 鞙勳箻頃� 雮滍墎 靷澊韸鸽姅 霊� 臧滌潣 韥措煬鞀ろ劙搿� 甑劚霅� 8臧滌潣 欤检殧 瓯措搿� 鞚措（鞏挫牳 鞛堨溂氅�, WuXi AppTec鞚� CRDMO 頂岆灚韽检潣 頃奠嫭 鞖旍唽鞛呺媹雼�. 鞚� 鞁滌劋鞚� 靹り硠電� '旮办垹瓿� 鞚戈皠 欷戩嫭鞚� 瓿奠儩'鞚� 臧曥“頃橃棳 鞖挫榿 須湪靹标臣 鞚戈皠 欷戩嫭 霐旍瀽鞚� 鞖旍唽毳� 瓴绊暕頄堨姷雼堧嫟. 鞚� 靷澊韸鸽姅 鞝� 靹戈硠 瓿犼皾鞐愱矊 頇旐暀, 靸濍頃� 氚� 韰岇姢韸� 靻旊（靺橃潉 膦呿暕鞝侅溂搿� 鞝滉车頃╇媹雼�.
WuXi AppTec (OTC:WUXAY), fournisseur mondial de services de R&D et de fabrication pour l'industrie pharmaceutique, a annonc茅 que son site de Nantong (Phase I) a remport茅 le prix Popular Choice Winner dans la cat茅gorie 芦 Factory & Warehouse 禄 aux Architizer A+Awards 2025.
Situ茅 dans la province du Jiangsu en Chine, le site de Nantong comprend huit b芒timents principaux r茅partis en deux clusters et constitue un 茅l茅ment cl茅 de la plateforme CRDMO de WuXi AppTec. Le design de l'installation met l'accent sur une 芦 symbiose technologique et humaniste 禄, alliant efficacit茅 op茅rationnelle et 茅l茅ments de design centr茅s sur l'humain. Le site offre des solutions compl猫tes en chimie, biologie et tests 脿 des clients du monde entier.
WuXi AppTec (OTC:WUXAY), ein globaler Anbieter von F&E- und Fertigungsdienstleistungen f眉r die Pharmaindustrie, gab bekannt, dass sein Standort Nantong (Phase I) den Popular Choice Winner Award in der Kategorie "Factory & Warehouse" bei den Architizer A+Awards 2025 gewonnen hat.
Der Standort Nantong in der Provinz Jiangsu, China, umfasst acht Hauptgeb盲ude, die in zwei Clustern angeordnet sind, und ist ein wichtiger Bestandteil der CRDMO-Plattform von WuXi AppTec. Das Design der Anlage legt Wert auf eine 鈥瀟echnologisch-humanistische Symbiose鈥� und verbindet operative Effizienz mit menschenzentrierten Designelementen. Der Standort bietet umfassende L枚sungen in Chemie, Biologie und Testverfahren f眉r globale Kunden.
- None.
- None.
The Architizer A+Awards, recognized as one of the most influential global architecture awards, celebrates groundbreaking designs that redefine functionality and aesthetics. Competing against thousands of entries from over 80 countries, WuXi AppTec's Nantong site stood out for its visionary design concept of 'technological-humanistic symbiosis'.
Located in
The Nantong site exemplifies WuXi AppTec's broader efforts to integrate technology, environmental sustainability, and community engagement into its operations and facilities. For instance, the Couvet site in
As a global enabling platform for the pharmaceutical and healthcare industry, WuXi AppTec is dedicated to building a brighter, healthier future where "every drug can be made and every disease can be treated."
About WuXi AppTec
As a global company with operations across
View original content to download multimedia:
SOURCE WuXi AppTec
FAQ
What award did WuXi AppTec's Nantong site win in 2025?
Where is WuXi AppTec's new award-winning facility located?
What services does WuXi AppTec's Nantong site provide?
What is the design concept of WuXi AppTec's Nantong facility?
